This call for nominations is held in tandem with Crest and Oral-B Together, We Can Conquer Cavities program. 

A new variant to the novel coronavirus—referred to as P.1—emerged in December in Manaus, Brazil. Its high level of infectivity led to a steep rise in COVID-19 cases in the area. Public health officials are concerned due to P.1’s ability to…

Cornell Thomas, DDS, has been appointed chief diversity officer and director of the Office of Diversity, Equity and Inclusion (DEI) at Southern Illinois University School of Dental Medicine

The number of new COVID-19 cases is decreasing across the United States, while the number of patients hospitalized due to COVID-19 illness is at the lowest level since mid-December. More than 30 states have experienced declines in new case…

Calculating your Second Draw Paycheck Protection Program (PPP) loan amount and navigating the loan forgiveness process can be complicated. This episode of The Art of Dental Finance and Management podcast helps break down the details…

The article “Pandemic considerations on essential oral healthcare” published in the Journal of Dental Research provides a layered model of essential oral healthcare, integrating urgent and basic oral healthcare, as well as advanced and…

As new, more infectious variants to the novel coronavirus spread across the world, Pfizer, in collaboration with its partner BioNTech, is developing a booster shot that would offer protection against new strains that may evolve. The company…

A multinational study of how the pathogen Porphyromonas gingivalis colonizes the oral cavity has led to new understanding of interactions within the oral microbiome. Given the fact P. gingivalis is unable to produce its own growth molecules…

The dark pigmentations that appear on dental enamel near the gingiva have a bacterial origin, and researchers note there is no definitive therapy to completely remove these stains. Appearing in Scientific Reports, a study of black stains…

Two vaccines developed to prevent infection with the novel coronavirus have been abandoned due to poor performance in clinical trials. Manufactured by Durham, North Carolina-based Merck in partnership with the nonprofit organization IAVI,…